Trial NCT00557830

View at ClinicalTrials.gov 
Org. Study IDs: AVJARCC0702

Last trial update was posted on 2013-07-18

MeSH Interventions

Sorafenib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Renal Cell Carcinoma

Stopping Reasons

The study was closed to enrollment when it became clear that enrollment was too slow to complete the full enrollment target within the time frame allowed.

Limitations And Caveats

The decision to close the study was made by the funder , Bayer HealthCare Pharmaceuticals, in collaboration with ACORN due to the low rate of accrual in light of study timelines and the lack of funds beyond the current level of support from Bayer.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID